Nasdaq · CIK 0001380106
RPID RAPID MICRO BIOSYSTEMS, INC.
Insider trading from SEC Form 4. Last filing May 26, 2026. Close $0.89 on Oct 9, 2026, +4% from the 52-week low and -81% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
RPIDOct 9, 2026 · close 0.89
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at RAPID MICRO BIOSYSTEMS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | Sean M Wirtjes CHIEF FINANCIAL OFFICER sell | $32k 7,480 shares | -1% | +121% from low-6% from high | |
| 48Moderate | Robert G. Spignesi Jr. PRESIDENT AND CEO sell | $74k 17,922 shares | -2% | +109% from low-12% from high | |
| 41Moderate | John J. Addington Wilson CHIEF OPERATING OFFICER sell | $41k 9,603 shares | -3% | +121% from low-6% from high | |
| 45Moderate | Sean M Wirtjes CHIEF FINANCIAL OFFICER sell | $68k 17,254 shares | -3% | +96% from low-17% from high | |
| 51Moderate | Robert G. Spignesi Jr. PRESIDENT AND CEO sell | $149k 38,327 shares | -3% | +101% from low-15% from high | |
| 35Weak | John J. Addington Wilson CHIEF OPERATING OFFICER sell | $21k 5,403 shares | -2% | +96% from low-17% from high | |
| 37Weak | Sean M Wirtjes CHIEF FINANCIAL OFFICER sell | $23k 6,027 shares | -1% | +89% from low-20% from high | |
| 47Moderate | Robert G. Spignesi Jr. PRESIDENT AND CEO sell | $49k 12,840 shares | -1% | +89% from low-20% from high | |
| 35Weak | John J. Addington Wilson CHIEF OPERATING OFFICER sell | $17k 4,610 shares | -2% | +89% from low-20% from high | |
| 59Moderate | Longitude Capital Partners II, LLC owner sell | $190k 49,000 shares | -100% | +96% from low-17% from high | |
| 29Weak | Longitude Capital Partners II, LLC owner sell | $474k 108,739 shares | -3% | +204% from low-11% from high | |
| 19Weak | Robert G. Spignesi Jr. PRESIDENT AND CEO sell | $79k 23,755 shares | -2% | +304% from low-14% from high | |
| 20Weak | Robert G. Spignesi Jr. PRESIDENT AND CEO sell | $117k 33,688 shares | -4% | +321% from low-10% from high | |
| 30Weak | Melinda Litherland Pei director buy | $20k 20,000 shares | +58% | - | |
| 25Weak | Melinda Litherland Pei director buy | $21k 20,000 shares | +140% | - |
Transactions
The last 62 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 21, 2026 | Dafni Bika director | AGrant or award Class A Common Stock | +19,300 | $0.00 | $0 | 19,300 | May 26, 2026 |
| May 21, 2026 | Dafni Bika director | AGrant or award Stock Option (Right to Buy)derivative | +38,700 | $0.00 | $0 | 38,700 | May 26, 2026 |
| May 20, 2026 | Bain Capital Life Sciences Investors, LLC owner | POpen-market purchase Pre-Funded Warrant (right to buy)derivativeindirect: See footnotes | +1,463,000 | - | - | 1,463,000 | May 22, 2026 |
| May 20, 2026 | Bain Capital Life Sciences Investors, LLC owner | POpen-market purchase Series A Warrant (right to buy)derivativeindirect: See footnotes | +1,463,000 | - | - | 1,463,000 | May 22, 2026 |
| May 20, 2026 | Bain Capital Life Sciences Investors, LLC owner | POpen-market purchase Series B Warrant (right to buy)derivativeindirect: See footnotes | +1,463,000 | - | - | 1,463,000 | May 22, 2026 |
| Mar 11, 2026 | Sean M Wirtjes CHIEF FINANCIAL OFFICER | SOpen-market sale Class A Common Stock | -7,480 | $4.32 | $32k | 556,194 | Mar 12, 2026 |
| Mar 11, 2026 | John J. Addington Wilson CHIEF OPERATING OFFICER | SOpen-market sale Class A Common Stock | -9,603 | $4.32 | $41k | 316,762 | Mar 12, 2026 |
| Mar 10, 2026 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -17,922 | $4.11 | $74k | 1,169,848 | Mar 12, 2026 |
| Feb 27, 2026 | Natale S Ricciardi director | MOption exercise Class A Common Stock | +842 | $0.75 | $632 | 29,442 | Mar 2, 2026 |
| Feb 27, 2026 | Natale S Ricciardi director | MOption exercise Stock Option (Right to Buy)derivative | -842 | $0.75 | $632 | 0 | Mar 2, 2026 |
| Feb 20, 2026 | Sean M Wirtjes CHIEF FINANCIAL OFFICER | SOpen-market sale Class A Common Stock | -17,254 | $3.92 | $68k | 563,674 | Feb 20, 2026 |
| Feb 20, 2026 | John J. Addington Wilson CHIEF OPERATING OFFICER | SOpen-market sale Class A Common Stock | -5,403 | $3.92 | $21k | 326,365 | Feb 20, 2026 |
| Feb 19, 2026 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -38,327 | $3.89 | $149k | 1,187,770 | Feb 20, 2026 |
| Feb 11, 2026 | John J. Addington Wilson CHIEF OPERATING OFFICER | AGrant or award Class A Common Stock | +74,000 | $0.00 | $0 | 331,768 | Feb 13, 2026 |
| Feb 11, 2026 | Sean M Wirtjes CHIEF FINANCIAL OFFICER | AGrant or award Class A Common Stock | +97,000 | $0.00 | $0 | 580,928 | Feb 13, 2026 |
| Feb 11, 2026 | Robert G. Spignesi Jr. PRESIDENT AND CEO | AGrant or award Class A Common Stock | +264,000 | $0.00 | $0 | 1,226,097 | Feb 13, 2026 |
| Feb 11, 2026 | Sean M Wirtjes CHIEF FINANCIAL OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +193,000 | $0.00 | $0 | 193,000 | Feb 13, 2026 |
| Feb 11, 2026 | John J. Addington Wilson CHIEF OPERATING OFFICER | AGrant or award Stock Option (Right to Buy)derivative | +147,000 | $0.00 | $0 | 147,000 | Feb 13, 2026 |
| Feb 11, 2026 | Robert G. Spignesi Jr. PRESIDENT AND CEO | AGrant or award Stock Option (Right to Buy)derivative | +528,000 | $0.00 | $0 | 528,000 | Feb 13, 2026 |
| Feb 9, 2026 | Sean M Wirtjes CHIEF FINANCIAL OFFICER | SOpen-market sale Class A Common Stock | -6,027 | $3.78 | $23k | 483,928 | Feb 10, 2026 |
| Feb 9, 2026 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -12,840 | $3.78 | $49k | 962,097 | Feb 10, 2026 |
| Feb 9, 2026 | John J. Addington Wilson CHIEF OPERATING OFFICER | SOpen-market sale Class A Common Stock | -4,610 | $3.78 | $17k | 257,768 | Feb 10, 2026 |
| Feb 4, 2026 | Longitude Capital Partners II, LLC owner | SOpen-market sale Class A Common Stockindirect: Held by Longitude Prime Fund, L.P. | -49,000 | $3.88 | $190k | 0 | Feb 6, 2026 |
| Jan 23, 2026 | Longitude Capital Partners II, LLC owner | XIn-the-money exercise Class A Common Stockindirect: Held by Longitude Venture Partners II, L.P. | +629,032 | $0.05 | $31k | 4,036,984 | Feb 3, 2026 |
| Jan 23, 2026 | Longitude Capital Partners II, LLC owner | SOpen-market sale Class A Common Stockindirect: Held by Longitude Venture Partners II, L.P. | -7,739 | $4.06 | $31k | 4,029,245 | Feb 3, 2026 |
| Jan 30, 2026 | Longitude Capital Partners II, LLC owner | SOpen-market sale Class A Common Stockindirect: Held by Longitude Prime Fund, L.P. | -46,000 | $4.54 | $209k | 104,000 | Feb 3, 2026 |
| Feb 2, 2026 | Longitude Capital Partners II, LLC owner | SOpen-market sale Class A Common Stockindirect: Held by Longitude Prime Fund, L.P. | -27,500 | $4.25 | $117k | 76,500 | Feb 3, 2026 |
| Feb 3, 2026 | Longitude Capital Partners II, LLC owner | SOpen-market sale Class A Common Stockindirect: Held by Longitude Prime Fund, L.P. | -27,500 | $4.24 | $117k | 49,000 | Feb 3, 2026 |
| Jan 23, 2026 | Longitude Capital Partners II, LLC owner | XIn-the-money exercise Class A Common Stockderivativeindirect: Held by Longitude Venture Partners II, L.P. | -500,000 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jan 23, 2026 | Longitude Capital Partners II, LLC owner | XIn-the-money exercise Class A Common Stockderivativeindirect: Held by Longitude Venture Partners II, L.P. | -129,032 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Nov 14, 2025 | Kirk Malloy director | GGift Class A Common Stock | -40,000 | $0.00 | $0 | 28,600 | Nov 18, 2025 |
| Oct 17, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +3,400 | $0.75 | $2,550 | 973,950 | Oct 21, 2025 |
| Oct 17, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | FTax withholding Class A Common Stock | -2,072 | $3.08 | $6,382 | 971,878 | Oct 21, 2025 |
| Oct 17, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +7,833 | $0.75 | $5,875 | 979,711 | Oct 21, 2025 |
| Oct 17, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | FTax withholding Class A Common Stock | -4,774 | $3.08 | $15k | 974,937 | Oct 21, 2025 |
| Oct 17, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative | -3,400 | $0.00 | $0 | 0 | Oct 21, 2025 |
| Oct 17, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Stock Option (Right to Buy)derivative | -7,833 | $0.00 | $0 | 0 | Oct 21, 2025 |
| Jul 11, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +25,145 | $0.00 | $0 | 969,160 | Jul 15, 2025 |
| Jul 11, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -11,874 | $3.33 | $39k | 957,286 | Jul 15, 2025 |
| Jul 14, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +25,145 | $0.00 | $0 | 982,431 | Jul 15, 2025 |
| Jul 14, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -11,881 | $3.32 | $39k | 970,550 | Jul 15, 2025 |
| Jul 8, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +25,144 | $0.00 | $0 | 897,510 | Jul 10, 2025 |
| Jul 8, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -10,824 | $3.51 | $38k | 886,686 | Jul 10, 2025 |
| Jul 9, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +25,144 | $0.00 | $0 | 911,830 | Jul 10, 2025 |
| Jul 9, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -11,247 | $3.51 | $39k | 900,583 | Jul 10, 2025 |
| Jul 10, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | MOption exercise Class A Common Stock | +25,145 | $0.00 | $0 | 925,728 | Jul 10, 2025 |
| Jul 10, 2025 | Robert G. Spignesi Jr. PRESIDENT AND CEO | SOpen-market sale Class A Common Stock | -11,617 | $3.40 | $39k | 944,015 | Jul 10, 2025 |
| May 22, 2025 | Dafni Bika director | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 27, 2025 |
| May 22, 2025 | Natale S Ricciardi director | AGrant or award Class A Common Stock | +14,300 | $0.00 | $0 | 28,600 | May 27, 2025 |
| May 22, 2025 | Melinda Litherland Pei director | AGrant or award Class A Common Stock | +14,300 | $0.00 | $0 | 68,600 | May 27, 2025 |
| May 22, 2025 | Kirk Malloy director | AGrant or award Class A Common Stock | +14,300 | $0.00 | $0 | 78,600 | May 27, 2025 |
| May 22, 2025 | Inese Lowenstein director | AGrant or award Class A Common Stock | +14,300 | $0.00 | $0 | 38,600 | May 27, 2025 |
| May 22, 2025 | Richard S Kollender director | AGrant or award Class A Common Stock | +14,300 | $0.00 | $0 | 111,018 | May 27, 2025 |
| May 22, 2025 | Inese Lowenstein director | AGrant or award Stock Option (Right to Buy)derivative | +28,650 | $0.00 | $0 | 28,650 | May 27, 2025 |
| May 22, 2025 | Kirk Malloy director | AGrant or award Stock Option (Right to Buy)derivative | +28,650 | $0.00 | $0 | 28,650 | May 27, 2025 |
| May 22, 2025 | Richard S Kollender director | AGrant or award Stock Option (Right to Buy)derivative | +28,650 | $0.00 | $0 | 28,650 | May 27, 2025 |
| May 22, 2025 | Melinda Litherland Pei director | AGrant or award Stock Option (Right to Buy)derivative | +28,650 | $0.00 | $0 | 28,650 | May 27, 2025 |
| May 22, 2025 | Natale S Ricciardi director | AGrant or award Stock Option (Right to Buy)derivative | +28,650 | $0.00 | $0 | 28,650 | May 27, 2025 |
| Dec 3, 2024 | Melinda Litherland Pei director | POpen-market purchase Class A Common Stock | +10,880 | $1.00 | $11k | 45,180 | Dec 5, 2024 |
| Dec 5, 2024 | Melinda Litherland Pei director | POpen-market purchase Class A Common Stock | +9,120 | $1.04 | $9,484 | 54,300 | Dec 5, 2024 |
| Nov 26, 2024 | Melinda Litherland Pei director | POpen-market purchase Class A Common Stock | +108 | $1.04 | $112 | 14,408 | Nov 27, 2024 |
| Nov 27, 2024 | Melinda Litherland Pei director | POpen-market purchase Class A Common Stock | +19,892 | $1.05 | $21k | 34,300 | Nov 27, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Bain Capital Life Sciences Investors, LLCowner
- Dafni Bikadirector
- Richard S Kollenderdirector
- Inese Lowensteindirector
- Longitude Capital Partners II, LLCowner
- Kirk Malloydirector
- Melinda Litherland Peidirector
- Natale S Ricciardidirector
- Robert G. Spignesi Jr.PRESIDENT AND CEO
- Sean M WirtjesCHIEF FINANCIAL OFFICER
- John J. Addington WilsonCHIEF OPERATING OFFICER
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.